Xenon Pharmaceuticals Inc

-1.11 (-4.29%)
Earnings Announcements

Xenon Pharmaceuticals Posts Quarterly Loss Per Share Of $0.36

Published: 11/10/2021 21:50 GMT
Xenon Pharmaceuticals Inc (XENE) - Xenon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update.
Q3 Revenue $8.1 Million Versus $6.6 Million.
Qtrly Loss per Share $0.36.
Xenon Pharmaceuticals - Qtrly Reported Total Revenue of $8.1 Million, Compared to $6.6 Million for Same Period in 2020.
Q3 Earnings per Share View $-0.38, Revenue View $10.2 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $7.34 Million
Adjusted EPS is expected to be -$0.35

Next Quarter Revenue Guidance is expected to be $1.34 Million
Next Quarter EPS Guidance is expected to be -$0.44

More details on our Analysts Page.